SpyGlass Pharma, Inc. (SGP) stock
SGPNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$29.68−1.75 (-5.58%)
Close on Nov 18, 2026Market cap $992.74MP/E –Yield –
SpyGlass Pharma cash
Cash and short-term investments held at the end of each period.
SpyGlass Pharma's cash was $223.14M at Jun 30, 2026. For fiscal 2025 it was $96.36M, up 492.3% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $96.36M | +492.3% |
| FY2024 | Dec 31, 2024 | $16.27M | +2.6% |
| FY2023 | Dec 31, 2023 | $15.85M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $223.14M | +284.7% |
| Q1 FY2026 | Mar 31, 2026 | $238.90M | +1368.5% |
| Q4 FY2025 | Dec 31, 2025 | $96.36M | +508.0% |
| Q2 FY2025 | Jun 30, 2025 | $127.24M | – |
| Q1 FY2025 | Mar 31, 2025 | $58.00M | – |
| Q4 FY2024 | Dec 31, 2024 | $16.27M | – |
| Q4 FY2023 | Dec 31, 2023 | $15.85M | – |
See a number that looks wrong?